REQUEST A DEMO
Total
USD $0.00
Search more companies

Organon Korea Co., Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Organon Korea Co., Ltd. Profile Updated: January 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Organon & Co is a global healthcare company with a diverse portfolio of medicines and solutions targeting women's health, fertility, medtech, biosimilars, and established brands. The company offers more than 60 medicines and products in women's health, a growing biosimilars business, and a large franchise of established medicines across various therapeutic areas. With a global supply chain network serving 140 markets, Organon claims to maintain the highest ethical standards. The company is focused on maximizing the potential of their existing women's health portfolio while pursuing business development opportunities.

Headquarters
4th Floor, 50, Jong-ro 1-gil Jongno-gu Seoul
Seoul; Seoul; Postal Code: 110150

Contact Details: Purchase the Organon Korea Co., Ltd. report to view the information.

Website: https://www.organon.com/korea/

Basic Information
Total Employees:
Purchase the Organon Korea Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Organon Korea Co., Ltd. report to view the information.
Incorporation Date:
February 01, 2021
Key Executives
Purchase this report to view the information.
CEO
Company Performance
Financial values in the chart are available after Organon Korea Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
8.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?